Overview
Ross Craigie practices in Manchester, United Kingdom. Mr. Craigie is rated as an Elite expert by MediFind in the treatment of Congenital Hyperinsulinism. His top areas of expertise are Congenital Hyperinsulinism, Low Blood Sugar, Rhabdomyosarcoma, Pancreatectomy, and Orchiectomy.
His clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Congenital Hyperinsulinism.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Congenital HyperinsulinismMr. Craigie isElite. Learn about Congenital Hyperinsulinism.
- Distinguished
- Low Blood SugarMr. Craigie isDistinguished. Learn about Low Blood Sugar.
- Advanced
- RhabdomyosarcomaMr. Craigie isAdvanced. Learn about Rhabdomyosarcoma.
- Teratoma of the MediastinumMr. Craigie isAdvanced. Learn about Teratoma of the Mediastinum.
- Experienced
- Adult Soft Tissue SarcomaMr. Craigie isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AnhidrosisMr. Craigie isExperienced. Learn about Anhidrosis.
- Esophageal AtresiaMr. Craigie isExperienced. Learn about Esophageal Atresia.
- FibrosarcomaMr. Craigie isExperienced. Learn about Fibrosarcoma.
- Horner SyndromeMr. Craigie isExperienced. Learn about Horner Syndrome.
- Leydig Cell Testicular TumorMr. Craigie isExperienced. Learn about Leydig Cell Testicular Tumor.